Ulta Beauty insider filing: 500 shares via Charles Schwab valued $264K

Rhea-AI Filing Summary

Form 144 filed for ULTA. The filer notifies a proposed sale of 500 shares of Ulta Beauty common stock through Charles Schwab & Co., Inc. with an aggregate market value of $264,215.00, an approximate sale date of 09/04/2025, and the securities exchange listed as NASDAQ. The filing shows total shares outstanding of 44,838,364. The 500 shares were acquired as equity compensation: 67 shares lapsed 09/19/2020 and 433 shares lapsed 06/03/2021, both from Ulta Beauty. The filer reports no securities sold in the past three months and signs the notice attesting no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small insider sale via Form 144, appears immaterial to company capitalization.

The notice documents a proposed sale of 500 shares valued at $264,215.00 against 44,838,364 shares outstanding, representing a de minimis portion of outstanding equity (well under 1%). The underlying shares were acquired through restricted stock lapses as equity compensation in 2020 and 2021. From a market-impact perspective this filing is routine disclosure of an insider transaction and is unlikely to materially affect ULTA's valuation or trading dynamics.

Corporate Governance Expert

TL;DR: Filing shows compliance with Rule 144 for sale of equity-compensation shares; no governance red flags present.

The Form 144 shows the seller followed the required notice procedures, including disclosure of acquisition dates and nature (restricted stock lapses). There are no recent sales reported in the past three months and the filer attests to the absence of undisclosed material information. This is consistent with standard insider liquidity events tied to vested compensation rather than abrupt departures or contested governance actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc 3000 Schwab Way Westlake TX 76262	500	264215.00	44838364	09/04/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/19/2020	Restricted Stock Lapse	ULTA BEAUTY, INC.			67	09/19/2020	Equity Compensation
Common	06/03/2021	Restricted Stock Lapse	ULTA BEAUTY, INC.			433	06/03/2021	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ULTA Form 144 report?

The filing reports a proposed sale of 500 common shares of Ulta Beauty with an aggregate market value of $264,215.00, to be sold on or about 09/04/2025 on NASDAQ.

Who is the broker handling the ULTA sale?

The broker listed is Charles Schwab & Co., Inc. at the address provided in the filing.

How were the shares acquired that are being sold?

All 500 shares were acquired as equity compensation: 67 shares lapsed on 09/19/2020 and 433 shares lapsed on 06/03/2021.

Have any ULTA securities been sold by this person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the filer assert there is any undisclosed material information?

By signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.